Daniel N. Swisher's Insider Trades & SAST Disclosures
Daniel N. Swisher's most recent trade in Corcept Therapeutics Inc was a trade of 2,200 Stock option (right to buy) done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel N. Swisher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,200 | 4,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 53.60 per share. | 10 Mar 2025 | 2,200 | 0 (0%) | 0% | 53.6 | 117,920 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.13 per share. | 10 Mar 2025 | 2,200 | 2,200 (0%) | 0% | 12.1 | 26,686 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.13 per share. | 10 Feb 2025 | 2,200 | 2,200 (0%) | 0% | 12.1 | 26,686 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,200 | 6,200 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 68.08 per share. | 10 Feb 2025 | 2,200 | 0 (0%) | 0% | 68.1 | 149,776 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.13 per share. | 10 Jan 2025 | 2,200 | 2,200 (0%) | 0% | 12.1 | 26,686 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2025 | 2,200 | 8,400 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 50.54 per share. | 10 Jan 2025 | 2,200 | 0 (0%) | 0% | 50.5 | 111,188 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 2,200 | 10,600 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 59.46 per share. | 10 Dec 2024 | 2,200 | 0 (0%) | 0% | 59.5 | 130,812 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.13 per share. | 10 Dec 2024 | 2,200 | 2,200 (0%) | 0% | 12.1 | 26,686 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.13 per share. | 11 Nov 2024 | 2,200 | 2,200 (0%) | 0% | 12.1 | 26,686 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,200 | 12,800 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 59.88 per share. | 11 Nov 2024 | 2,200 | 0 (0%) | 0% | 59.9 | 131,736 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 Aug 2024 | 150 | 150 (0%) | 0% | 5.9 | 879 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 38.50 per share. | 01 Aug 2024 | 150 | 0 (0%) | 0% | 38.5 | 5,775 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 150 | 0 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 Jul 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 2,200 | 150 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 32.81 per share. | 01 Jul 2024 | 2,200 | 0 (0%) | 0% | 32.8 | 72,182 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 05 Jun 2024 | 40,000 | 147,045 (0%) | 0% | 5 | 200,000 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 03 Jun 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 2,200 | 2,350 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 03 Jun 2024 | 2,200 | 0 (0%) | 0% | 30.2 | 66,462 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 09 May 2024 | 2,500 | 107,045 (0%) | 0% | 1.9 | 4,689 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 23.09 per share. | 01 May 2024 | 2,200 | 0 (0%) | 0% | 23.1 | 50,798 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 2,200 | 4,550 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 May 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 Apr 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 2,200 | - | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 25.30 per share. | 01 Apr 2024 | 2,200 | 0 (0%) | 0% | 25.3 | 55,660 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 01 Mar 2024 | 2,200 | 0 (0%) | 0% | 23.6 | 51,898 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,200 | 8,950 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 Mar 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | N. Swisher Daniel | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 01 Feb 2024 | 2,200 | 0 (0%) | 0% | 22 | 48,400 | Common Stock |
| Corcept Therapeutics Inc | Swisher N. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 2,200 | 11,150 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 Feb 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | N. Daniel Swisher | Director | Sale of securities on an exchange or to another person at price $ 22.11 per share. | 02 Jan 2024 | 2,200 | 0 (0%) | 0% | 22.1 | 48,642 | Common Stock |
| Corcept Therapeutics Inc | N. Swisher Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 2,200 | 13,350 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Swisher N. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 02 Jan 2024 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | Swisher N. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 01 Dec 2023 | 2,200 | 2,200 (0%) | 0% | 5.9 | 12,892 | Common Stock |
| Corcept Therapeutics Inc | N. Swisher Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 2,200 | 15,550 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 25.47 per share. | 01 Dec 2023 | 2,200 | 0 (0%) | 0% | 25.5 | 56,034 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 07 Aug 2023 | 2,200 | 650 (0%) | 0% | 30.1 | 66,308 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 07 Aug 2023 | 2,200 | 2,200 (0%) | 0% | 6.6 | 14,410 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 2,200 | 5,300 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.86 per share. | 07 Aug 2023 | 650 | 2,850 (0%) | 0% | 5.9 | 3,809 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 30.16 per share. | 07 Aug 2023 | 650 | 0 (0%) | 0% | 30.2 | 19,601 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 650 | 49,350 | - | - | Stock option (right to buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 07 Jun 2023 | 40,000 | 104,545 (0%) | 0% | 5 | 200,000 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 26 May 2023 | 5,000 | 118,808 (0%) | 0% | 1.9 | 9,535 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 13,456 | 60,440 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.78 per share. | 03 Mar 2023 | 5,426 | 55,014 (0%) | 0% | 142.8 | 774,724 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Other type of transaction at price $ 0.00 per share. | 05 Dec 2022 | 10,465 | 46,984 (0%) | 0% | 0 | Ordinary Shares | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 12,500 | 0 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 3.91 per share. | 10 Nov 2022 | 12,500 | 113,808 (0%) | 0% | 3.9 | 48,875 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.19 per share. | 10 Nov 2022 | 12,500 | 126,308 (0%) | 0% | 3.2 | 39,875 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 20,000 | 7,500 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 08 Aug 2022 | 20,000 | 20,000 (0%) | 0% | 6.6 | 131,000 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 28.32 per share. | 08 Aug 2022 | 15,385 | 0 (0%) | 0% | 28.3 | 435,703 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.39 per share. | 08 Aug 2022 | 4,615 | 15,385 (0%) | 0% | 28.4 | 131,020 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 39,866 | 39,866 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,454 | 113,808 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 13,507 | 62,053 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.96 per share. | 03 Mar 2022 | 4,802 | 57,251 (0%) | 0% | 154.0 | 739,316 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.01 per share. | 03 Jan 2022 | 1,624 | 48,546 (0%) | 0% | 131.0 | 212,760 | Ordinary Shares |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 21.70 per share. | 02 Sep 2021 | 7,500 | 0 (0%) | 0% | 21.7 | 162,741 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 7,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 02 Sep 2021 | 7,500 | 7,500 (0%) | 0% | 6.6 | 49,125 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 6.25 per share. | 04 Aug 2021 | 12,877 | 93,354 (0%) | 0% | 6.2 | 80,481 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2021 | 12,877 | 0 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.86 per share. | 04 Aug 2021 | 12,877 | 106,231 (0%) | 0% | 2.9 | 36,828 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 02 Jun 2021 | 7,500 | 7,500 (0%) | 0% | 6.6 | 49,125 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 7,500 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 21.48 per share. | 02 Jun 2021 | 7,500 | 0 (0%) | 0% | 21.5 | 161,085 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 35,295 | 35,295 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 17,525 | 93,354 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 15,961 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 15,961 | 75,829 (0%) | 0% | - | Common Stock | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 5,000 | 0 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 5.75 per share. | 18 May 2021 | 5,000 | 59,868 (0%) | 0% | 5.7 | 28,735 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 18 May 2021 | 5,000 | 64,868 (0%) | 0% | 2.9 | 14,500 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 7,500 | 42,500 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 24.14 per share. | 05 Apr 2021 | 7,500 | 0 (0%) | 0% | 24.1 | 181,037 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 05 Apr 2021 | 7,500 | 7,500 (0%) | 0% | 6.6 | 49,125 | Common Stock |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.75 per share. | 05 Mar 2021 | 3,718 | 49,961 (0%) | 0% | 164.8 | 612,541 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 11,695 | 53,679 (0%) | 0% | 0 | Ordinary Shares | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 10,000 | 5,000 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 16 Feb 2021 | 10,000 | 69,868 (0%) | 0% | 2.9 | 29,000 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 16 Feb 2021 | 10,000 | 59,868 (0%) | 0% | 7.8 | 77,797 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 28.74 per share. | 19 Jan 2021 | 5,000 | 0 (0%) | 0% | 28.7 | 143,687 | Common Stock |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 5,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Jan 2021 | 5,000 | 5,000 (0%) | 0% | 6.6 | 32,750 | Common Stock |
| Jazz Pharmaceuticals plc | Daniel N. Swisher | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 160.40 per share. | 04 Jan 2021 | 1,607 | 41,984 (0%) | 0% | 160.4 | 257,763 | Ordinary Shares |
| Cerus Corp. | Daniel N. Swisher | Director | Sale of securities on an exchange or to another person at price $ 6.25 per share. | 17 Nov 2020 | 10,000 | 59,868 (0%) | 0% | 6.3 | 62,505 | Common Stock |
| Cerus Corp. | Daniel N. Swisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 10,000 | 15,000 | - | - | Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges